Navigation Links
ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
Date:2/6/2008

RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury, today reported results for the second quarter and first six months of fiscal 2008.

Revenues for the quarter ended December 31, 2007, were $5.5 million. This compares with revenues of $3.7 million for the second quarter of fiscal 2007 and $3.6 million for the first quarter of fiscal 2008. Total disposable revenues were $2.6 million, a 44 percent increase over disposable revenues of $1.8 million in the second quarter a year ago.

The Company reported a net loss of $1.7 million, or $0.03 per share, in the second quarter of fiscal 2008, versus a loss of $2.0 million, or $0.04 per share, in the second quarter a year ago. At December 31, 2007, ThermoGenesis had $30.5 million in cash, cash equivalents and short-term investments. Total cancellable backlog at the end of the second fiscal quarter was $3.9 million, a 50 percent increase over the $2.6 million in cancellable backlog a year ago.

"As we discussed in our January 10th update news release, the primary growth drivers during the quarter were increased AXP(TM) AutoXpress Platform (AXP) bag set shipments, improved BioArchive(R) System sales and growth in CryoSeal(R) FS System and disposable sales," noted Dr. William Osgood, the Company's Chief Executive Officer.

Osgood said the Company's results reflect its success in addressing AXP bag set production quality. In addition, the Company shipped 8 BioArchive devices during the quarter which compares to 3 devices shipped in the prior year same quarter, bringing the total number of installed BioArchiv
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
10. Helix BioPharma Corp. announces fiscal 2007 results
11. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...IEGO, Nov. 9 BioMed Real...the company has received commitments from lenders ...d line of credit by $65 million to an aggregate of...of the facility. The weighted-average effective i....35% as of September 30, 2009. The maturity date r...
(Date:11/9/2009)... Four of the top 10 pharmaceutical g...ubmissions to Health Canada. Datafarm’s anno...th Canadian DIA Annual Meeting where Health Canada...nies may submit Hybrid eCTD regulatory submissions...o prior permission request. , ...
(Date:11/7/2009)...IDGE, Mass., Nov. 7, Research proj...scored top marks this evening, as Tim Kunisky of L...an (Jack) Chen of Audubon, PA received the highest...ens Competition in Math, Science & Technology,...ion. ,, ( http://www.newscom.com/cgi-bin/prnh/...
(Date:11/6/2009)...IENNA, Austria, November 6 EUCODIS...nufacturing, and marketing enzymes for the,chemica...o a research,agreement with Bio Sidus, the leading..., The agreement gives EUCODIS Bioscience exclu...t - to Bio Sidus, proprietary collection of,psychr...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
... Vista Partners announced,today that it has update...(Nasdaq: ABMC ) and maintains its twelve month ta...arch at Vista Partners stated, "Sales,internationa... alliance,which give ABMC,s products exposure in n...ell. Once the company receives CLIA approval from ...
...er le Fbre has demonstrated that a field-emission ... of thousands of nanometre-sharp needles. These pr...ge media with an extremely high density, using bit... hard disk is now reaching its technical limits be...ead. Consequently, the capacity of the disk and th...
Genmab's 2007 Annual Report
Other Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2
(Date:11/9/2009)...s from around the world will gather in Boston Nov....gets and Cancer Therapeutics International Confere... on important cancer therapies in development. ,...ectively we need a greater understanding of the ac...aid Lewis Cantley, Ph.D., director of the cancer c...
(Date:11/8/2009)...due University have discovered a new approach for ...ries using nano-spheres that could be injected int...thetic "copolymer micelles" are drug-delivery sphe...0 times smaller than the diameter of a red blood c...iver drugs for cancer treatment and other therapie...
(Date:11/8/2009)...H INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR HE...olving adults with intellectual disabilities found...nowledge after taking a semi-weekly class for four...cepted term for mental retardation, have slightly ...reventable chronic diseases compared to the genera...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Blood Thinner May Prevent Chemo Related Clots 55837 1Blood Thinner May Prevent Chemo Related Clots 55837 2Health Plan Executives to Share Winning Strategies in the Age of Reform During Health Integrated Forum 55832 1Health Plan Executives to Share Winning Strategies in the Age of Reform During Health Integrated Forum 55832 2Aflac Announces Support for Childhood Cancer Awareness Month 55827 1Aflac Announces Support for Childhood Cancer Awareness Month 55827 2Aflac Announces Support for Childhood Cancer Awareness Month 55827 3Aflac Announces Support for Childhood Cancer Awareness Month 55827 4Aflac Announces Support for Childhood Cancer Awareness Month 55827 5
... discoveries about the timing and speed of giganti...ut of the ground 65 million years ago could shift ...s of India are one of Earth,s largest lava flows e...th the climate of the Earth - if they erupted and ...ench and Indian geologists have now identified a 6...
... new surgical assistant at the University of North...hree arms, a computerized brain and a glowing trac... cancerous prostates, bypass blocked coronary arte...bid obesity. , The new arrival is a robotic machin...ntuitive Surgical. UNC currently is the only gynec...
...an effort to understand the biological function of... Ambros (Darmouth Medical School) have studied the...d loss-of-function phenotype of Drosophila mir-1 (...A, whose expression in mouse and humans is limited...study shows that, in Drosophila embryos, mir-1 exp...
Other Biology News:India's smoking gun: Dino-killing eruptions 2India's smoking gun: Dino-killing eruptions 3FDA: 'Highly Unlikely' Green Tea Lowers Cancer Risk 2FDA: 'Highly Unlikely' Green Tea Lowers Cancer Risk 3
Rabbit Anti-TCP-1 alpha (H-110) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Anti-Renal Cell Carcinoma Marker (gp200) Ab-1 Monoclonal Antibody, Unconjugated from Lab Vision
...bryonic Stem Cell (hESC) Starter Kit brings togeth...lturing hESCs as soon as possible. This set of pro...ses around the world, including those supported by...ely tested using GIBCO's quality process and has b...
Feline IFN-alpha, Unconjugated from R&D Systems
Biology Products: